BioCentury
ARTICLE | Clinical News

MolecularBreeding molecular evolution technology regulatory update

October 23, 2000 7:00 AM UTC

MAXY received U.S. Patent No. 6,132,970 covering its DNAShuffling recombination technology, including use of a single screening cycle, and its application to enzymes, antibodies, cancer therapeutics, ...